Can you take Lutetium lu 177 vipivotide tetraxetan with Provella?
2 drug interactions and 4 additional warnings found for the following 2 drugs:
- lutetium lu 177 vipivotide tetraxetan
- Provella (bifidobacterium infantis/lactobacillus acidophilus)
Drug interactions
Moderate drug interactions
Moderate:
lactobacillus acidophilus lutetium Lu 177 vipivotide tetraxetan
Applies to: Provella (bifidobacterium infantis / lactobacillus acidophilus) and lutetium lu 177 vipivotide tetraxetan
If you are currently being treated or have recently been treated with lutetium Lu 177 vipivotide tetraxetan, you should let your doctor know before using lactobacillus acidophilus. Depending on the dose and length of time you have been on lutetium Lu 177 vipivotide tetraxetan, you may be at risk for developing rare infections from exposure to products containing live bacteria or yeast. Depending on your overall health and medical condition, it may be advisable to avoid using lactobacillus acidophilus until your immune system has recovered from the effects of lutetium Lu 177 vipivotide tetraxetan. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Moderate:
bifidobacterium infantis lutetium Lu 177 vipivotide tetraxetan
Applies to: Provella (bifidobacterium infantis / lactobacillus acidophilus) and lutetium lu 177 vipivotide tetraxetan
If you are currently being treated or have recently been treated with lutetium Lu 177 vipivotide tetraxetan, you should let your doctor know before using bifidobacterium infantis. Depending on the dose and length of time you have been on lutetium Lu 177 vipivotide tetraxetan, you may be at risk for developing rare infections from exposure to products containing live bacteria or yeast. Depending on your overall health and medical condition, it may be advisable to avoid using bifidobacterium infantis until your immune system has recovered from the effects of lutetium Lu 177 vipivotide tetraxetan. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Disease interactions
4 potential interactions Applies to: 3 conditions, including Immunodeficiency, Renal Dysfunction, and Bone Marrow Depression/Low Blood Counts.
Bone Marrow Depression/Low Blood Counts
Moderate:
lutetium lu 177 vipivotide tetraxetan
lutetium Lu 177 vipivotide tetraxetan has a moderate potential interaction with Bone Marrow Depression/Low Blood Counts.
Lutetium Lu 177 vipivotide tetraxetan can cause severe and life-threatening myelosuppression (including anemia, thrombocytopenia, leukopenia, neutropenia); caution is recommended in at-risk patients. Complete blood counts should be performed before and during therapy.
Immunodeficiency
Moderate:
lutetium lu 177 vipivotide tetraxetan
lutetium Lu 177 vipivotide tetraxetan has a moderate potential interaction with Immunodeficiency.
Lutetium Lu 177 vipivotide tetraxetan can cause severe and life-threatening myelosuppression (including anemia, thrombocytopenia, leukopenia, neutropenia); caution is recommended in at-risk patients. Complete blood counts should be performed before and during therapy.
Moderate:
Provella
The bifidobacterium infantis and lactobacillus acidophilus in Provella both have a moderate potential interaction with Immunodeficiency.
Probiotics, especially those containing lactobacillus, should be used with caution in immunosuppressed patients.
Renal Dysfunction
Moderate:
lutetium lu 177 vipivotide tetraxetan
lutetium Lu 177 vipivotide tetraxetan has a moderate potential interaction with Renal Dysfunction.
Exposure of lutetium Lu 177 vipivotide tetraxetan is expected to increase with the degree of renal dysfunction. No dose adjustment is recommended for patients with mild (baseline CrCl 60 to 89 mL/min by Cockcroft-Gault) to moderate (CrCl 30 to 59 mL/min) renal dysfunction; as these patients may be at greater risk of toxicity, renal function and adverse reactions should be monitored frequently. Pharmacokinetics and safety of lutetium Lu 177 vipivotide tetraxetan have not been studied in patients with severe (CrCl 15 to 29 mL/min) renal dysfunction or end-stage renal disease; caution is advised in these patients.
Report options
More resources
lutetium lu 177 vipivotide tetraxetan
A total of 224 drugs are known to interact with lutetium lu 177 vipivotide tetraxetan.
- Lutetium lu 177 vipivotide tetraxetan is in the drug class therapeutic radiopharmaceuticals.
- Lutetium lu 177 vipivotide tetraxetan is used to treat Prostate Cancer.
Provella
A total of 370 drugs are known to interact with Provella.
- Provella is in the drug class probiotics.
- Provella is used to treat Dietary Supplementation.
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.